Trial Outcomes & Findings for Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair (NCT NCT02062437)

NCT ID: NCT02062437

Last Updated: 2017-05-31

Results Overview

* Surgical incidents. * Post-operative complications. * Failure and revisions analysis.

Recruitment status

COMPLETED

Target enrollment

132 participants

Primary outcome timeframe

2-year follow-up visit

Results posted on

2017-05-31

Participant Flow

All patients who received the same Total Hip Replacement system for primary hip replacement between July and October 2010 were contacted for study participation.

Participant milestones

Participant milestones
Measure
Total Hip Replacement Using a Ceramic Friction Pair
All patients were treated with a total hip replacement using a ceramic friction pair Biolox® delta, with a Meije Duo® cementless stem with HAP associated with a cementless double coating of plasma sprayed titanium and HAP Dynacup® acetabular cup.
Overall Study
STARTED
132
Overall Study
COMPLETED
80
Overall Study
NOT COMPLETED
52

Reasons for withdrawal

Reasons for withdrawal
Measure
Total Hip Replacement Using a Ceramic Friction Pair
All patients were treated with a total hip replacement using a ceramic friction pair Biolox® delta, with a Meije Duo® cementless stem with HAP associated with a cementless double coating of plasma sprayed titanium and HAP Dynacup® acetabular cup.
Overall Study
Pt. didn't want to come for the 2y visit
31
Overall Study
Patient not available for the 2y visit
18
Overall Study
Death
2
Overall Study
Pt. couldn't come due to med. condition
1

Baseline Characteristics

Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Total Hip Replacement Using a Ceramic Friction Pair
n=80 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
Age, Continuous
59.8 years
STANDARD_DEVIATION 9.0 • n=5 Participants
Sex: Female, Male
Female
38 Participants
n=5 Participants
Sex: Female, Male
Male
42 Participants
n=5 Participants
Region of Enrollment
France
80 participants
n=5 Participants

PRIMARY outcome

Timeframe: 2-year follow-up visit

Population: The total of 80 patients were seen for their 2-Year follow-up visit.

* Surgical incidents. * Post-operative complications. * Failure and revisions analysis.

Outcome measures

Outcome measures
Measure
Total Hip Replacement Using a Ceramic Friction Pair
n=80 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
Number of Participants With Adverse Events
2 participants

SECONDARY outcome

Timeframe: Baseline

Population: 80 patients were available but per-protocol some pre-operative data were not available for the analysis of mobilities

Mobility of the hip is assessed by the maximum value in the range of motions, expressed in degrees (°). Normal values (usually observed range of motions) are: extension (from 0 to 30°), flexion (from 0 to 120°), abduction (from 0 to 45°), adduction (from 0 to 30°), external rotation (from 0 to 45°) and internal rotation (from 0 to 45°). Higher values are the best and a negative value indicates that the patient(s) can't reach the minimum normal range of motion.

Outcome measures

Outcome measures
Measure
Total Hip Replacement Using a Ceramic Friction Pair
n=45 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
General Performance: Mobility
Extension
-1 Degrees
Standard Deviation 6
General Performance: Mobility
Flexion
89 Degrees
Standard Deviation 12
General Performance: Mobility
Adduction
17 Degrees
Standard Deviation 9
General Performance: Mobility
Abduction
20 Degrees
Standard Deviation 10
General Performance: Mobility
External rotation
20 Degrees
Standard Deviation 9
General Performance: Mobility
Internal rotation
7 Degrees
Standard Deviation 13

SECONDARY outcome

Timeframe: 2-year Follow-up visit

Population: 80 patients were available but per-protocol some pre-operative data were not available for the analysis of mobilities

Mobility of the hip is assessed by the maximum value in the range of motions, expressed in degrees (°). Normal values (usually observed range of motions) are: extension (from 0 to 30°), flexion (from 0 to 120°), abduction (from 0 to 45°), adduction (from 0 to 30°), external rotation (from 0 to 45°) and internal rotation (from 0 to 45°). Higher values are the best and a negative value indicates that the patient(s) can't reach the minimum normal range of motion.

Outcome measures

Outcome measures
Measure
Total Hip Replacement Using a Ceramic Friction Pair
n=45 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
General Performance: Mobility
Extension
0 Degrees
Standard Deviation 1
General Performance: Mobility
Flexion
107 Degrees
Standard Deviation 13
General Performance: Mobility
Adduction
26 Degrees
Standard Deviation 9
General Performance: Mobility
Abduction
34 Degrees
Standard Deviation 9
General Performance: Mobility
External rotation
30 Degrees
Standard Deviation 7
General Performance: Mobility
Internal rotation
21 Degrees
Standard Deviation 9

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline

Population: Within per protocol population, data were not complete to calculate the total PMA score for 3 patients at 2-year visit.

Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 0 to 6 points (0 is the worst possible score and 18 is the best possible PMA score).

Outcome measures

Outcome measures
Measure
Total Hip Replacement Using a Ceramic Friction Pair
n=77 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
General Performance: Objective Clinical Score (PMA)
Pain score
1.9 score on a scale
Standard Deviation 1.1
General Performance: Objective Clinical Score (PMA)
Mobility score
5.1 score on a scale
Standard Deviation 0.9
General Performance: Objective Clinical Score (PMA)
Walking score
4.5 score on a scale
Standard Deviation 0.7
General Performance: Objective Clinical Score (PMA)
Total PMA score
11.5 score on a scale
Standard Deviation 1.7

OTHER_PRE_SPECIFIED outcome

Timeframe: 2-year follow-up visit

Population: Within per protocol population, data were not complete to calculate the total PMA score for 3 patients at 2-year visit.

Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 0 to 6 points (0 is the worst possible score and 18 is the best possible PMA score).

Outcome measures

Outcome measures
Measure
Total Hip Replacement Using a Ceramic Friction Pair
n=77 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
General Performance: Objective Clinical Score (PMA)
Pain score
5.8 score on a scale
Standard Deviation 0.6
General Performance: Objective Clinical Score (PMA)
Mobility score
6.0 score on a scale
Standard Deviation 1.0
General Performance: Objective Clinical Score (PMA)
Walking score
5.9 score on a scale
Standard Deviation 0.5
General Performance: Objective Clinical Score (PMA)
Total PMA score
17.7 score on a scale
Standard Deviation 1.0

OTHER_PRE_SPECIFIED outcome

Timeframe: 2-year Follow-up visit

Population: Patients with X-ray data available

Radiological assessment is based on : * Cup radiological signs of osteolysis or radiolucencies. * Stem radiological signs of osteolysis or radiolucencies. * Ossifications according to Brooker classification from class I: Ossification around the hip joint. to class IV: shows apparent bone ankylosis of the hip. (i.e Class 0 = no ossification) * Other Radiological signs

Outcome measures

Outcome measures
Measure
Total Hip Replacement Using a Ceramic Friction Pair
n=80 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
General Performance: Radiological Assessment.
Ossifications (Brooker classification = 4)
0 participants
General Performance: Radiological Assessment.
Other radiological signs
0 participants
General Performance: Radiological Assessment.
Cups without radiological signs
80 participants
General Performance: Radiological Assessment.
Stems without radiological signs
80 participants
General Performance: Radiological Assessment.
Ossifications (Brooker classification = 0)
70 participants
General Performance: Radiological Assessment.
Ossifications (Brooker classification = 1)
6 participants
General Performance: Radiological Assessment.
Ossifications (Brooker classification = 2)
2 participants
General Performance: Radiological Assessment.
Ossifications (Brooker classification = 3)
2 participants

Adverse Events

Total Hip Replacement Using a Ceramic Friction Pair

Serious events: 1 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Total Hip Replacement Using a Ceramic Friction Pair
n=80 participants at risk
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
Musculoskeletal and connective tissue disorders
Femoral fracture
1.2%
1/80 • Number of events 1 • 2 years
Adverse events were collected from surgery to last follow-up visit

Other adverse events

Other adverse events
Measure
Total Hip Replacement Using a Ceramic Friction Pair
n=80 participants at risk
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
Musculoskeletal and connective tissue disorders
Fracture during surgery
1.2%
1/80 • Number of events 1 • 2 years
Adverse events were collected from surgery to last follow-up visit

Additional Information

Nathalie Trétout

Tornier SAS

Phone: +33 4 76 71 35 00

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60